Madison, Wis. – Greater Madison biotechnology executives should stop worrying too much about raising capital and focus on mastering a new biotech business model, according to life science venture investor G. Steven Burrill.
Burrill, founder of Burrill & Co. in San Francisco, is considered a pioneer in the world of biotechnology investing. The Madison native returned to his alma mater Thursday to deliver a lecture in the Microbial Science Building on the University of Wisconsin-Madison campus.